期刊文献+

罗格列酮联用维甲酸在体内对直肠癌HCT-15细胞COX-2、MMP-7、TIMP-1表达的影响

In vivo effect of rosiglitazone combined with all-trans retinoic acid on the expression of COX-2、MMP-7、TIMP-1 0f rectal cancer HCT-15 cells
暂未订购
导出
摘要 目的:研究罗格列酮(ROS)联用全反式维甲酸(ATRA)对直肠癌裸鼠移植瘤HCT-15细胞COX-2、MMP-7、TIMP-1表达的影响,并初步探讨其抗肿瘤的机制。方法:建立直肠癌裸鼠移植瘤模型,荷瘤裸鼠随机分为未用药组、ROS组(ROS 25 mg.kg-1.2d-1)、ATRA组(ATRA 11mg.kg-1.2d-1)、ATRA联用ROS组[(ROS 25 mg+ATRA 11 mg).kg-1.2d-1]。灌胃40 d后,观察各组裸鼠移植瘤体积变化;利用免疫组化SP法观察移植瘤细胞中COX-2、MMP-7、TIMP-1的表达。结果:1)用药3组瘤体体积与未用药组比较均缩小,差别有统计学意义(P<0.05),ATRA联用ROS组的荷瘤体积缩小更明显(P<0.05);ROS组与ATRA组瘤体体积相当(P>0.05);2)用药3组移植瘤细胞内COX-2、MMP-7、TIMP-1的表达与未用药组比较均降低(P<0.05),且ROS组与ATRA组移植瘤细胞内COX-2、MMP-7、TIMP-1下降更明显(P<0.01),ROS组与ATRA组移植瘤细胞内三者的表达相当(P>0.05)。结论:ROS与ATRA均有一定的抑瘤作用,ROS与ATRA联用可发挥协同抗肿瘤的作用,可能是通过抑制移植瘤细胞内COX-2、MMP-7、TIMP-1的表达而实现。 Objective: To investigate the effect of rosiglitazone(ROS) combined with all-trans retinoic acid(ATRA) on the expression of COX-2、MMP-7、TIMP-1 of transplanted rectal cancer in nude mice,and to explore the mechanism of anti-carcinoma preliminarily.Methods: Established the modle of transplanted tumor in node mice by inoculating human rectal cancer cell line HCT-15 into the right back of nude mice subcutaneously.The cancer-bearing nude mice were divided randomly into 4 groups: group 1 with no drugs,group 2 with ROS(ROS 25 mg)·kg-1·2d-1,group 3 with ATRA(ATRA 11 mg·kg-1·2d-1),group 4 ROS combined with ATRA [(ROS 25 mg+ ATRA 11mg)·kg-1·2d-1].After treated for 40 days,the volume change of tumor were observed.The expression of COX-2、MMP-7、TIMP-1 in transplanted tumor cells were detected by immunohistochemical.Results: 1)The volumes of tumor were significantly decreased in group 2、3、4 compared with group 1(P0.05),The volume of tumor in group 4 was significantly decreased compared with group 2、3(P0.05),The volume of tumor in group 2 was similar to group3(P0.05).2)The expression of COX-2、MMP-7、TIMP-1 in transplanted tumor were significantly decreased in group 2、3、4 compared with group 1(P0.05),The expression of COX-2、MMP-7、TIMP-1 in group 4 were significantly decreased compared with group 2、3(P0.01).The expression of these three in group2 and group3 were quite(P0.05).Conclusion: ROS and ATRA can inhibit the growth of tumor and ROS combined with ATRA can further inhibit the growth of tumor.The mechanism maybe that ROS and ATRA can inhibit expression of COX-2、MMP-7、TIMP-1.
出处 《中国现代普通外科进展》 CAS 2011年第7期505-508,共4页 Chinese Journal of Current Advances in General Surgery
关键词 罗格列酮 维甲酸 环氧化酶-2 基质金属蛋白酶 组织型基质金属蛋白酶抑制物 Rosiglitazone·All trans retinoic acid·Cyclooxygenase·Matrix metalloproteinase·Tissue inhibitor of metalloproteinase
  • 相关文献

参考文献11

  • 1Coelho SM, Vaisman M,Carvalho DP. Tumour re-differentiation ef- fect of retinoic acid:a novel therapeulic approach for advanced thy- roid cancer[J]. Curr Pharm Des,2005,11 ( 19):2525-2531.
  • 2季宇彬,蔡林,陈晓光.ROZ与ATRA联合应用对MCF-7细胞诱导作用[J].哈尔滨商业大学学报(自然科学版),2008,24(1):1-6. 被引量:1
  • 3Berthiaume M, Sell H, Lalonde.J, et al .Actions of PPAR gamma agonism on adipose tissue remodeling, insulin sensitivity, and ipemia in absence of glucocorticoids [J]. Am J Physiol Regul Integr Comp Physiol, 2004,287(5):1116-1123.
  • 4Osawa E, Nakajima A, Wada K, et al. Peroxisome proliferator acti- vated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice[J]. Gastroenterology, 2003,124:361-367.
  • 5Fauconnet S, Lascombel I,Chabannes E,et al. Differential regulation of vascvlar endothelial growth factor expression by peroxisome pro- liferator-activated recepters in bladder cancer cells [J].J Boil Chem, 2002,277:23534-23543.
  • 6Kasper HV, Konze E,Dienes HP, et al. COX-2 Expression and Ef- fects of COX-2 Inhibition in Colorectal Carcinomas and their Liver Metastases[J].Anticancer Research, 2010,30(6):2017-2024.
  • 7饶雪峰,刘伟中,廖传文,彭贵祖,单人锋.MMP-7在肝细胞癌组织中的表达及临床意义[J].世界华人消化杂志,2009,17(28):2903-2907. 被引量:3
  • 8Horndler C, Gallego R, Gareia-Albeniz X, et al. Co-expression of matrix metalloproteinase-7 (MMP-7) and phosphorylated insulin growth factor receptor1 (pIGF-1R) correlates with poor prognosis in patients with wild-type KRAS treated with cetuximah or panitu- mumab[J]. Cancer Bio Ther, 2011,11 (2):177-183.
  • 9Sorensen NM, Sorensen IV, Wurtz SO, et al. Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment [J]. Stand J Gastroenterol, 2008,43 (7): 774-786.
  • 10Giaginis C, Nikiteas N, Margeli A. et al. Serum tissue inhibitor of metalloproteinases 1 and 2 (TIMP-1 and TIMP-2)levels in cnl- orectal cancer patients:associations with clinicopathological vari- ables and patients survival[J], Int J Binl Markers, 2009,24(4):245- 252.

二级参考文献22

  • 1高宝辉,谢丽微,祁旦已,赵志光,谢小志,王宗敏.MMP-7、MVO在子宫内膜样腺癌中的表达[J].实用肿瘤学杂志,2004,18(5):343-346. 被引量:3
  • 2周彦明,殷正丰,杨甲梅.PPARγ激动剂抗肿瘤作用的研究进展[J].第二军医大学学报,2005,26(11):1290-1292. 被引量:6
  • 3李政霄,彭振辉,纪泛扑,袁景奕,潘敏,刘艳,王琼.上皮钙粘素和β-连环蛋白在皮肤Bowen病、鳞癌中的表达[J].南方医科大学学报,2006,26(8):1245-1247. 被引量:2
  • 4周小娟,郑棋,赵小丽,马海琳.榄香烯联合三苯氧胺对乳腺癌MCF-7细胞株的抑制效应[J].西安交通大学学报(医学版),2007,28(1):74-77. 被引量:10
  • 5Takeuchi N, Ichikawa Y, Ishikawa T, Momiyama N, Hasegawa S, Nagashima Y, Miyazaki K, Koshikawa N, Mitsuhashi M, Shimada H. Matrilysin gene expression in sporadic and familial colorectal adenomas. Mol Carcinog 1997; 19: 225-229.
  • 6Crawford HC, Scoggins CR, Washington MK, Matrisian LM, Leach SD. Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Invest 2002;109: 1437-1444.
  • 7Rath T, Roderfeld M, Graf J, Wagner S, Vehr AK, Dietrich C, Geier A, Roeb E. Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential? Inflamm Bowel Dis 2006; 12: 1025-1035.
  • 8Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001; 114: 111-118.
  • 9Ozaki I, Yamamoto K, Mizuta T, Setoguchi Y, Morito F, Sakai T. Detection of matrix metalloproteinase gene expression by reverse transcription-polymerase chain reaction in human hepatocellular carcinoma. Int Hepatol Commun 1996; 6: 36-42.
  • 10Ishii Y, Nakasato Y, Kobayashi S, Yamazaki Y, Aoki T. A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma. J Exp Clin Cancer Res 2003; 22: 461-470.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部